Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Current Opinion in Oncology
|
May 21, 2014
Optimal duration of systemic treatment in metastatic colorectal cancer
Lieke H J Simkens, Miriam Koopman, Cornelis J A Punt
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2015
Systemic treatment: maintenance compared with holiday
Cornelis J A Punt, Lieke H J Simkens, Miriam Koopman
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2017
Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group
Johannes J M Kwakman, Lieke H J Simkens, Linda Mol, et al.
Plos One
|
November 7, 2014
Statin use is not associated with improved progression free survival in cetuximab treated KRAS mutant metastatic colorectal cancer patients: results from the CAIRO2 study
Lisanne L Krens, Lieke H J Simkens, Jara M Baas, et al.
International Journal of Cancer
|
October 17, 2022
A propensity score-matched analysis of oncological outcome after systemic therapy for stage IV colorectal cancer: Impact of synchronous ovarian metastases
Richard van der Meer, Checca Bakkers, Felice N van Erning, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 2, 2011
Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy
Lieke H J Simkens, Miriam Koopman, Linda Mol, et al.
Journal of Cancer Research and Clinical Oncology
|
December 20, 2022
Biomarker concordance between primary colorectal cancer and ovarian metastases: a Dutch cohort study
Richard van der Meer, Judith W M Jeuken, Steven L Bosch, et al.
Journal of the Society for Gynecologic Investigation
|
June 29, 2004
Aging blunts remodeling of the uterine artery during murine pregnancy
Olivier W H van der Heijden, Yvonne P G Essers, Lieke H J Simkens, et al.
Plos One
|
July 5, 2013
Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer
Sjoerd T Ligthart, Frank A W Coumans, Francois-Clement Bidard, et al.
International Journal of Cancer
|
June 19, 2025
Real-world study on fluoropyrimidine-related toxicity outcomes in cancer patients with select DPYD variant alleles that received DPYD genotype-guided dosing
Sofía L J Peeters, Didier Meulendijks, Zerina Kadric, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Current Opinion in Oncology
|
May 21, 2014
Optimal duration of systemic treatment in metastatic colorectal cancer
Lieke H J Simkens, Miriam Koopman, Cornelis J A Punt
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2015
Systemic treatment: maintenance compared with holiday
Cornelis J A Punt, Lieke H J Simkens, Miriam Koopman
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2017
Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group
Johannes J M Kwakman, Lieke H J Simkens, Linda Mol, et al.
Plos One
|
November 7, 2014
Statin use is not associated with improved progression free survival in cetuximab treated KRAS mutant metastatic colorectal cancer patients: results from the CAIRO2 study
Lisanne L Krens, Lieke H J Simkens, Jara M Baas, et al.
International Journal of Cancer
|
October 17, 2022
A propensity score-matched analysis of oncological outcome after systemic therapy for stage IV colorectal cancer: Impact of synchronous ovarian metastases
Richard van der Meer, Checca Bakkers, Felice N van Erning, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 2, 2011
Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy
Lieke H J Simkens, Miriam Koopman, Linda Mol, et al.
Journal of Cancer Research and Clinical Oncology
|
December 20, 2022
Biomarker concordance between primary colorectal cancer and ovarian metastases: a Dutch cohort study
Richard van der Meer, Judith W M Jeuken, Steven L Bosch, et al.
Journal of the Society for Gynecologic Investigation
|
June 29, 2004
Aging blunts remodeling of the uterine artery during murine pregnancy
Olivier W H van der Heijden, Yvonne P G Essers, Lieke H J Simkens, et al.
Plos One
|
July 5, 2013
Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer
Sjoerd T Ligthart, Frank A W Coumans, Francois-Clement Bidard, et al.
International Journal of Cancer
|
June 19, 2025
Real-world study on fluoropyrimidine-related toxicity outcomes in cancer patients with select DPYD variant alleles that received DPYD genotype-guided dosing
Sofía L J Peeters, Didier Meulendijks, Zerina Kadric, et al.
Page
of 2